Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 28, 2024 16:01 ET | Source: Eledon Pharmaceuticals, Inc.

Eledon Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Operating and Financial Results

Eledon Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Operating and Financial Results
March 25, 2024 16:56 ET | Source: Eledon Pharmaceuticals, Inc.

Eledon Pharmaceuticals Announces 12th Participant Enrolled in Phase 2 BESTOW Trial Evaluating Tegoprubart for the Prevention of Organ Rejection

Eledon Pharmaceuticals Announces 12th Participant Enrolled in Phase 2 BESTOW Trial Evaluating Tegoprubart for the Prevention of Organ Rejection
March 21, 2024 10:31 ET | Source: Eledon Pharmaceuticals, Inc.

Eledon Pharmaceuticals Announces Use of Tegoprubart in First-ever Transplant of Genetically Modified Kidney from a Pig to a Human

Eledon Pharmaceuticals Announces Use of Tegoprubart in First-ever Transplant of Genetically Modified Kidney from a Pig to a Human
February 13, 2024 19:01 ET | Source: Eledon Pharmaceuticals, Inc.

Eledon Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Eledon Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
January 04, 2024 16:40 ET | Source: Eledon Pharmaceuticals, Inc.

Eledon Pharmaceuticals Highlights Recent Business Milestones and Provides 2024 Outlook

Eledon Pharmaceuticals Highlights Recent Business Milestones and Provides 2024 Outlook
December 04, 2023 18:00 ET | Source: Eledon Pharmaceuticals, Inc.

Eledon Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Eledon Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
November 29, 2023 16:05 ET | Source: Eledon Pharmaceuticals, Inc.

Eledon Pharmaceuticals to Present at Noble Capital Markets' Emerging Growth Equity Conference

Eledon Pharmaceuticals to Present at Noble Capital Markets' Emerging Growth Equity Conference
November 09, 2023 16:01 ET | Source: Eledon Pharmaceuticals, Inc.

Eledon Pharmaceuticals Reports Third Quarter 2023 Operating and Financial Results

Eledon Pharmaceuticals Reports Third Quarter 2023 Operating and Financial Results
November 08, 2023 16:05 ET | Source: Eledon Pharmaceuticals, Inc.

Eledon Pharmaceuticals to Present at Jefferies London Healthcare Conference

Eledon Pharmaceuticals to Present at Jefferies London Healthcare Conference
November 02, 2023 09:05 ET | Source: Eledon Pharmaceuticals, Inc.

Eledon Reports Updated Data from Ongoing Phase 1b Trial Evaluating Tegoprubart for Prevention of Rejection in Kidney Transplantation

Eledon Reports Updated Data from Ongoing Phase 1b Trial Evaluating Tegoprubart for Prevention of Rejection in Kidney Transplantation

keyboard_arrow_left Previous Page

Next Page keyboard_arrow_right